Thieme integrates Certara Chemaxon’s new generation chemical sketcher, Marvin, into its chemical databases Science of Synthesis and Pharmaceutical Substances Announcement Thieme integrates Certara Chemaxon’s new generation chemical sketcher, Marvin, into its chemical databases Science of Synthesis and Pharmaceutical Substances Latest version of Marvin is more accurate and user-friendly for Chemical Database Subscribers Stuttgart, Germany…Danielle PillsburyApril 14, 2026
EFMC International Symposium on Medicinal Chemistry 2026 Conference EFMC International Symposium on Medicinal Chemistry 2026 CertaraApril 13, 2026
CDISC SEND Updates Nonclinical Drug Developers Need to Know Blog CDISC SEND Updates Nonclinical Drug Developers Need to Know In this blog, Peggy Zorn explores updates to the Standard for Exchange of Nonclinical Data…CertaraApril 6, 2026
Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations Webinar Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations Danielle PillsburyApril 2, 2026
Transforming regulatory writing with CoAuthor™ Video Transforming regulatory writing with CoAuthor™ Book a no-obligation demo to see how CoAuthor can revolutionize your regulatory writing processes.Accelerate submission…Danielle PillsburyMarch 31, 2026
Data Fabrics in Pharma: Connecting Data for Better Decisions Blog Data Fabrics in Pharma: Connecting Data for Better Decisions Learn how a data fabric in pharma connects siloed systems. Explore the benefits of data…CertaraMarch 31, 2026
Discovery & Development Europe 2026 Conference Discovery & Development Europe 2026 CertaraMarch 13, 2026
Certara Announces 2026 Certainty Event Announcement Certara Announces 2026 Certainty Event Certainty 2026: Explore AI-driven drug development and technological innovation at the leading biosimulation event for…CertaraMarch 9, 2026
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance Press Release Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…CertaraFebruary 26, 2026
Ready for ESG NextGen, or still submitting like it’s 2015? On-Demand Webinar Ready for ESG NextGen, or still submitting like it’s 2015? Learn how to prepare for ESG NextGen with automated, compliant submission workflows. Watch the webinar…CertaraFebruary 5, 2026